Skip to content

Starting HAART at higher CD4 cell counts means treatment can be safely stopped for longer

15% of patients who fail treatment with NRTI, NNRTIs and PIs die within 3 years

Adding ddI achieves fall in viral load in HAART patients with resistance

Abacavir leads to better CD4 increase than AZT when combined with 3TC and EFV

Peg-IFN achieves poor results in HIV-HCV patients even when used with ribavirin

Should treatment breaks be guided by CD4? Study suggests yes

South Africa: MCC back pedals on nevirapine for mums to be

HIV-positive Brazilian women find adherence hard

Tenofovir no more likely than d4T to cause kidney side-effects

Use drug holidays cautiously in NNRTI-treated patients

Once-daily abacavir safe and effective - ICAAC late breaker

Start HAART rather than HCV therapy first, suggests Canadian research

Give HIV/HCV patients up to 18 months of HCV therapy, say Spanish

HCV coinfection associated with an increased risk of diabetes in HIV-positive US veterans

Saliva may have infectious amounts of HCV in presence of high HCV viral load and gum disease

Nevirapine, efavirenz and Kaletra regimens best for treatment naive

HIV positive gay/bisexual men much more likely to be diagnosed with secondary syphilis

High doses of vitamin C lower indinavir levels